|
Sodium Chloride (NaCl) 0.9 % Clinical Trials
1 actively recruiting trial across 1 location
Birmingham, Alabama1 trial
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
University of Alabama
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.